CNDT Conduent Inc.

Conduent Market-Leading Disease Surveillance and Outbreak Management System to Fight Coronavirus

Conduent Market-Leading Disease Surveillance and Outbreak Management System to Fight Coronavirus

Company’s Flexible Platform, Maven®, Already Customized and Implemented by Government and Health Organizations to Track, Manage and Report Confirmed Coronavirus Cases

Conduent to Configure and Deploy Coronavirus Tracking Module for Additional Government and Health Organizations Seeking Support

FLORHAM PARK, N.J., Feb. 06, 2020 (GLOBE NEWSWIRE) -- (Nasdaq: CNDT) today announced a version of its disease surveillance and outbreak management platform, Maven®, to securely track, manage and report on cases of the coronavirus, 2019-nCov.

is a software platform developed for organizations, including government agencies, to manage cases of more than 90 communicable diseases. Its flexible design gives organizations the capability to customize disease tracking most prevalent in specific geographies or communities. 

Conduent will host the platform’s coronavirus-enabled version of Maven in the company’s secure cloud so public health agencies and other organizations can get immediate access to use it. Conduent expects its coronavirus module to be available within the month. Additionally, those with advanced training also can leverage the solution’s flexibility to customize the Maven platform on their own to track coronavirus.

Based on an organization’s need, Maven has the capability to track diseases such as influenza, tuberculosis and Ebola. More than 40 organizations are currently using Maven, and some have already taken advantage of the platform’s flexibility by configuring it to track the coronavirus’s spread within their respective locations. Conduent is also actively facilitating sharing of best practices between clients as they configure their systems to track the outbreak.

“Maven is a valuable tool that organizations can use to identify and follow up on people who may have come into contact with a person infected with a communicable or infectious disease,” said Mark Brewer, President, Global Public Sector Solutions, Conduent. “In the absence of a vaccine, tracking and analyzing who is at risk from contact with an infected person is one of the most important methods available to contain diseases like the coronavirus and prevent widespread outbreaks.

“Maven’s technology is scalable and can be quickly and easily configured to changing technologies, protocols and geographic locations — all of which are keys to effective disease outbreak response. It is also designed to allow for easier data sharing and integration among health agencies on the front lines of battling the disease.”

Designed with rich contact tracing, outbreak management and detection, state and local health organizations can collaborate to quickly and effectively contain public health crises. Epidemiologists can use Maven’s reporting capability to search and analyze the centralized data collected to discover trends and patterns. Maven can also be used to report externally, supporting the need for automatic case reporting to the Centers for Disease Control and Prevention in the United States, the World Health Organization, or local authorities.

About Conduent

Conduent delivers mission-critical ​services and solutions on behalf of businesses and governments – creating exceptional outcomes for its clients and the millions of people who count on them. Through people, process and technology, Conduent solutions and services automate workflows, improve efficiencies, reduce costs and enable revenue growth. It’s why most Fortune 100 companies and over 500 government entities depend on Conduent every day to manage their essential interactions and move their operations forward. 

Conduent’s differentiated services and solutions improve experiences for millions of people every day, including two-thirds of all  in the U.S., 11 million employees who use its , and nearly nine million people who travel through daily. Conduent’s solutions deliver exceptional outcomes for its clients including $16 billion in medical bill savings, up to 40% efficiency increase in HR operations, and up to 40% improvement in processing costs, while driving higher end-user satisfaction. Learn more at . 

Media Contacts:

Sean Collins, Conduent, ,

Neil Franz, Conduent, ,

Investor Relations Contacts:

Alan Katz, Conduent, ,

Rebecca Koar, Conduent, ,

Note: To receive RSS news feeds, visit . For open commentary, industry perspectives and views, visit , or .

Conduent is a trademark of Conduent Incorporated in the United States and/or other countries.

EN
06/02/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Conduent Inc.

Conduent Inc: 1 director

A director at Conduent Inc bought 100,000 shares at 2.810USD and the significance rating of the trade was 83/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly ...

 PRESS RELEASE

Conduent Reports First Quarter 2025 Financial Results

Conduent Reports First Quarter 2025 Financial Results Key Q1 2025 Highlights Revenue and Adj. Revenue(1): $751MPre-tax Income (Loss): $(56)MAdj. EBITDA Margin(1): 4.9%New Business Signings ACV(2): $109MNet ARR Activity Metric(2) (TTM): $116M FLORHAM PARK, N.J., May 07, 2025 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions and services company, today announced its first quarter 2025 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Conduent had a good start to 2025, especially amidst the ...

 PRESS RELEASE

Conduent Reports Fourth Quarter and Full Year 2024 Financial Results

Conduent Reports Fourth Quarter and Full Year 2024 Financial Results Key Q4 and Full Year 2024 Highlights Revenue: Q4 $800M / FY $3,356MAdj. Revenue(1): Q4 $800M / FY $3,176MPre-tax Income (Loss): Q4 $(82)M / FY $504MAdj. EBITDA Margin(1): Q4 4.0% / FY 3.9%New Business Signings ACV(2): Q4 $137M / FY $485MNet ARR Activity Metric(2) (TTM): $92M FLORHAM PARK, N.J., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions and services company, today announced its fourth quarter and full year 2024 financial results. Cliff Ske...

Conduent Incorporated: Credit profile pressured amid turnaround

Our credit view of this issuer reflects its very good liquidity, against its competitive challenges pressure operating performance.

 PRESS RELEASE

Conduent Reports Third Quarter 2024 Financial Results

Conduent Reports Third Quarter 2024 Financial Results Key Q3 2024 Highlights Revenue: $807MAdj. Revenue(1): $781MPre-tax Income: $159MAdj. EBITDA Margin(1): 4.1%New Business Signings ACV(2): $111MNet ARR Activity Metric(2) (TTM): $46M FLORHAM PARK, N.J., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Conduent Incorporated (Nasdaq: CNDT), a global technology-led business process solutions and services company, today announced its third quarter 2024 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “All in all, Q3 was a sequentially improved quarter where we me...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch